SpectraPhase
Austin
About SpectraPhase
SpectraPhase proposes to develop, patent and commercialize technology for a blood glucose monitor that takes continuous readings on a real-time basis. With superior diagnostic data, hospital ICU staff can properly manage patients' blood sugar levels and expect both better patient outcomes and significant cost reductions for ICU administrators. SpectraPhase is led by CEO Chris Condit, a graduate student at UT, and founding member of CardioSpectra, an Austin-based medical diagnostics startup that successfully sold for $63M in 2007.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (Dec 2010)
Industries & Categories
Developer Platform, Health Care, Information Services, Information Technology
Canonical: https://fsome.com/organization/spectraphase-374347 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.